This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Concordia University, Marquette University. Active years: 2020.
Company Filing History:
1 out of 28 
1 out of 71 
Years Active: 2020
Title: Terrence S Neumann: Innovator in Estrogen Receptor Research
Introduction
Terrence S Neumann is a notable inventor based in Milwaukee, WI (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target the estrogen receptor beta isoform.
Latest Patents
Neumann holds a patent for "Substituted (4'-hydroxyphenyl)cyclohexane compounds and uses thereof as selective agonists of the estrogen receptor beta isoform." This patent discloses substituted (4'-hydroxylphenyl)cycloalkane compounds and their use as selective agonists of the estrogen receptor beta isoform (ERβ). The disclosed compounds may be formulated as pharmaceutical compositions and administered to treat diseases associated with ER activity, such as proliferative diseases and disorders and/or psychiatric diseases or disorders. He has 1 patent to his name.
Career Highlights
Throughout his career, Neumann has worked with esteemed institutions such as Marquette University and Concordia University. His research has focused on innovative approaches to treating diseases linked to estrogen receptor activity.
Collaborations
Neumann has collaborated with notable individuals in his field, including William A Donaldson and Daniel S Sem. Their combined expertise has contributed to advancements in understanding estrogen receptor mechanisms.
Conclusion
Terrence S Neumann's work in developing selective agonists for the estrogen receptor beta isoform showcases his commitment to advancing medical science. His contributions are significant in the ongoing quest to treat various diseases effectively.